Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 55 Records) |
Query Trace: Lung Neoplasms and MYC[original query] |
---|
Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report. The Journal of international medical research 2021 8 49 (8): 3000605211035005. Yang Zhengyuan, Lin Yingcheng, Wang Hongbi |
The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors. Annals of translational medicine 2021 7 9 (9): 779. Li Jingwen, Xiang Chan, Wang Yue, Zhou Yan, Cao Shuhui, Ling Xuxinyi, Ye Junyi, Zheng Jingjing, Shao Lin, Zhong Hua, Han Yuch |
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
Diverse alterations associated with resistance to KRAS(G12C) inhibition. Nature 2021 11 599 (7886): 679-683. Zhao Yulei, Murciano-Goroff Yonina R, Xue Jenny Y, Ang Agnes, Lucas Jessica, Mai Trang T, Da Cruz Paula Arnaud F, Saiki Anne Y, Mohn Deanna, Achanta Pragathi, Sisk Ann E, Arora Kanika S, Roy Rohan S, Kim Dongsung, Li Chuanchuan, Lim Lee P, Li Mark, Bahr Amber, Loomis Brian R, de Stanchina Elisa, Reis-Filho Jorge S, Weigelt Britta, Berger Michael, Riely Gregory, Arbour Kathryn C, Lipford J Russell, Li Bob T, Lito Pi |
A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance. Frontiers in oncology 2021 10 11 722039. Liu Li, Qu Jingjing, Heng Jianfu, Zhou Chunhua, Xiong Yi, Yang Haiyan, Jiang Wenjuan, Zeng Liang, Zhu Songlin, Zhang Yongchang, Tan Jiarong, Hu Chengping, Deng Pengbo, Yang No |
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer. Journal of translational medicine 2022 Sep 20 (1): 390. Wang Chunyue, Zhang Zhenlong, Sun Yulan, Wang Song, Wu Mengmeng, Ou Qiuxiang, Xu Yang, Chen Zhiming, Shao Yang, Liu Hong, Hou Peife |
Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: A case-control study. Cancer medicine 2022 Jun . Ji Yangtao, Yang Yue, Yin Zhih |
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma. Translational lung cancer research 2022 3 11 (2): 238-249. Chen Ying, Xu Jinhe, Zhang Lei, Song Yingfang, Wen Wen, Lu Jun, Zhao Zhongquan, Kong Wencui, Liu Wei, Guo Aiping, Santarpia Mariacarmela, Yamada Tadaaki, Cai Xiuyu, Yu Zongya |
Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations. Journal of cancer research and clinical oncology 2022 3 148 (5): 1265-1268. Han Chao, Ding Xuan, Li Mengmeng, Luo Ningning, Qi Yingxue, Wang Chengw |
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
Evaluate the Prognosis of MYC/TP53 Comutation in Chinese Patients with EGFR-Positive Advanced NSCLC Using Next-Generation Sequencing: A Retrospective Study. Technology in cancer research & treatment 2022 12 21 15330338221138213. Cao Jin, J Gu Juan, Liang Yichen, Wang Buh |
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature communications 2023 8 14 (1): 4980. Anna Skakodub, Henry Walch, Kathryn R Tringale, Jordan Eichholz, Brandon S Imber, Harish N Vasudevan, Bob T Li, Nelson S Moss, Kenny Kwok Hei Yu, Boris A Mueller, Simon Powell, Pedram Razavi, Helena A Yu, Jorge S Reis-Filho, Daniel Gomez, Nikolaus Schultz, Luke R G Pi |
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 7 182 107292. Georgios Tsakonas, Vasisht Tadigotla, Sudipto K Chakrabortty, Giuseppe Stragliotto, Dalin Chan, Rolf Lewensohn, Wei Yu, Johan K Skog, Per Hydbring, Simon Ekm |
The HDAC2-MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c-Myc and cyclin D1. Molecular carcinogenesis 2023 7 . Bin Wang, Xiao-Yong Shen, Lin-Yue Pan, Zheng Li, Chun-Ji Chen, Yuan-Shan Yao, Dong-Fang Tang, Wen G |
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology 2023 6 . Todd M Bauer, Kathleen N Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Anna V Tinker, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne Jones, David Spigel, Siqing |
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2023 5 188 81-89. Yiquan Xu, Jingjing Yan, Chengzhi Zhou, Lin Wu, Haibo Wang, Jun Zhao, Maolin Zhou, Jingyi Wang, Xinlong Zheng, Longfeng Zhang, Kan Jiang, Xiaobin Zheng, Qian Miao, Shiwen Wu, Zihua Zou, Rong Lian, Yuange He, Rongrong Chen, Shanshan Yang, Yujing Li, Sihui Chen, Gen L |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network. Translational lung cancer research 2023 12 12 (11): 2245-2259. Peng Liang, Hongsheng Deng, Yi Zhao, Ying Chen, Jingna Zhang, Jianxing He, Wenhua Lia |
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Journal of neuro-oncology 2023 10 . Kaixuan Bai, Xin Chen, Xuejiao Qi, Yu Zhang, Yueli Zou, Jian Li, Lili Yu, Yuanyuan Li, Jiajia Jiang, Yi Yang, Yajing Liu, Shuanghao Feng, Hui |
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer cell 2023 10 . Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, Jian Carrot-Zha |
Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107927. Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip, Ying-Chun |
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies. Clinical lung cancer 2024 8 . Margaret R Smith, Yuezhu Wang, Caroline B Dixon, Ralph D'Agostino, Yin Liu, Jimmy Ruiz, George Oliver, Lance D Miller, Umit Topaloglu, Michael D Chan, Michael Farris, Jing Su, Kathryn F Mileham, Wencheng Li, Jason M Grayson, Thomas Lycan, Fei Xi |
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways. Computers in biology and medicine 2024 4 174 108346. Salvatore D'Antona, Danilo Porro, Francesca Gallivanone, Gloria Berto |
Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy. Frontiers in genetics 2024 12 15 1475511. Xixi Gao, Yingqing Zhang, Ming Zhang, Yuejiao S |
Clinical significance of a prospective large genomic screening for small-cell lung cancer: the genetic classification and a biomarker driven phase II trial of gedatolisib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 10 . Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, Haruyasu Murakami, Haruko Daga, Ryo Toyozawa, Toshiyuki Kozuki, Jun Sakakibara-Konishi, Yuichiro Ohe, Masahiro Morise, Terufumi Kato, Masato Shingyoji, Satoshi Hara, Naoki Furuya, Shuhei Teranishi, Saori Takata, Shingo Miyamoto, Ichiro Nakachi, Masashi Wakabayashi, Shogo Nomura, Akihiro Sato, Genichiro Ishii, Katsuya Tsuchihara, Eri Sugiyama, Keisuke Kirita, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, Kaname Nosaki, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Go |
- Page last reviewed:Feb 1, 2024
- Content source: